Implications of the accuracy of MEPS prescription drug data for health services research

Inquiry

Volumn 48, Issue 3, 2011, Pages 242-259

  Hill, Steven C ^a   Zuvekas, Samuel H ^a   Zodet, Marc W ^a  

^a AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRESCRIPTION DRUG;

AGED; ARTICLE; DRUG UTILIZATION; ECONOMICS; FEE; FEMALE; HEALTH SERVICES RESEARCH; HUMAN; INFORMATION PROCESSING; MALE; MEDICARE; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; SOCIOECONOMICS; STATISTICS; UNITED STATES;

AGED; AGED, 80 AND OVER; DATA COLLECTION; DRUG UTILIZATION; FEMALE; HEALTH SERVICES RESEARCH; HUMANS; MALE; MEDICARE PART D; MIDDLE AGED; PRESCRIPTION DRUGS; PRESCRIPTION FEES; REPRODUCIBILITY OF RESULTS; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84856324380     PISSN: 00469580     EISSN: None     Source Type: Journal    
DOI: 10.5034/inquiryjrnl_48.03.04     Document Type: Article

References (31)

1. Aday, L. A., and R. Andersen. 1974. A Framework for the Study of Access to Medical Care. Health Services Research 9(3):208-220.
2. Boudreau, D. M., J. R. Daling, K. E. Malone, J. S. Gardner, D. K. Blough, and S. R. Heckbert. 2004. A Validation Study of Patient Interview Data and Pharmacy Records for Antihypertensive, Statin, and Antidepressant Medication Use among Older Women. American Journal of Epidemiology 159(3):308-317.
3. Caskie, G. I. L., and S. L. Willis. 2004. Congruence of Self-Reported Medications with Pharmacy Prescription Records in Low-Income Older Adults. The Gerontologist 44(2):176-185.
4. Caskie, G. I. L., S.L.Willis, W. Schaie, and F.A.K. Zanjani. 2006. Congruence of Medication Information from a Brown Bag Data Collection and Pharmacy Records: Findings from the Seattle Longitudinal Study. Experimental Aging Research 32(1):79-103.
5. Centers for Medicare andMedicaid Services (CMS). 2010. The Medicare Current Beneficiary Survey and the New Part D Data. Presentation at the 2010 Part D Symposium, Baltimore, Md. http://www.cms.gov/PrescriptionDrugCovGenIn/09_ProgramReports.asp. Accessed November 4, 2010.
6. Cohen, J. 1997. Design and Methods of the Medical Expenditure Panel Survey Household Component. Rockville, Md.: Agency for Health Care Policy and Research. http://www.meps.ahrq.gov/mepsweb/data_files/publications/mr1/mr1.pdf. Accessed December 8, 2010.
7. Cohen, S. 1997. Sample Design of the 1996 Medical Expenditure Panel Survey Household Component. Rockville, Md.: Agency for Health Care Policy and Research. http://www.meps.ahrq.gov/mepsweb/data_files/publications/mr2/mr2.pdf. Accessed December 8, 2010.
8. Cohen, S. 2003. Design Strategies and Innovations in the Medical Expenditure Panel Survey. Medical Care Supplement 41:III-5-III-12.
9. Curtis, J. R., A. O. Westfall, J. Allison, A. Freeman, S. H. Kovac, and K. G. Saag. 2006. Agreement and Validity of Pharmacy Data Versus Self-Report for Use of Osteoporosis Medications among Chronic Glucocorticoid Users. Pharmacoepidemiology and Drug Safety 15(10):710-718.
10. Ezzati-Rice, T. M., D. Kashihara, and S. R. Machlin. 2004. Health Care Expenses in the United States, 2000. Rockville, Md.: Agency for Healthcare Research and Quality. http://www.meps.ahrq.gov/mepsweb/data_files/publications/rf21/rf21.shtml. Accessed December 8, 2010.
11. Haapae, M., J. Miettunen, S. Lindeman, M. Joukamaa, and H. Koponen. 2010. Agreement between Self-Reported and Pharmacy Data on Medication Use in the Northern Finland 1966 Birth Cohort. International Journal of Methods in Psychiatric Research 19(2):88-96.
12. Hill, S. C., and G. E. Miller. 2010. Health Expenditure Estimation and Functional Form: Applications of the Generalized Gamma and Extended Estimating Equations Models. Health Economics 19(5):608-627.
13. Klungel, O. H., A. de Boer, A. H. P. Paes, R. M. C. Herings, J. C. Seidell, and A. Bakker. 2000. Influence of Question Structure on the Recall of Self-reported Drug Use. Journal of Clinical Epidemiology 53(3):273-277.
14. Kwon, A., K. M. Bungay, Y. Pei, W. H. Rogers, I. B. Wilson, Q. Zhou, and D. A. Adler. 2003. Antidepressant Use: Concordance Between Self-Report and Claims Records. Medical Care 41(3):368-374.
15. Landis, J. R., and G. G. Koch. 1977. The Measurement of Observer Agreement for Categorical Data. Biometrics 33(1):159-174.
16. Lin, L. 1989. A Concordance Correlation Coefficient to Evaluate Reproducibility. Biometrics 45(1):255-268.
17. Metlay, J. P., C. Hardy, and B. L. Strom. 2002. Agreement between Patient Self-Report and a Veterans Affairs National Pharmacy Database for Identifying Recent Exposures to Antibiotics. Pharmacoepidemiology and Drug Safety 12(1):9-15.
18. Moeller, J. F., M. N. Stagnitti, E. Horan, P. Ward, N. Kieffer, and E. Hock. 2001. Outpatient Prescription Drugs; Data Collection and Editing in the 1996 Medical Expenditure Panel Survey (HC-010A) MEPS Methodology Report No. 12.AHRQPub.No. 01-0002. Rockville, Md.: Agency for Healthcare Research and Quality.
19. Monster, T. B. M., W. M. T. Janssen, P. E. de Jong, and L. T. W. de Jong-van den Berg. 2002. Pharmacy Data in Epidemiological Studies: An Easy To Obtain and Reliable Tool. Pharmacoepidemiology and Drug Safety 11(5):379-384.
20. Nielsen, M. W., B. Søndergaard, M. Kjøller, and E. H. Hansen. 2008. Agreement between Self-Reported Data on Medicine Use and Prescription Records Vary According to Method of Analysis and Therapeutic Group. Journal of Clinical Epidemiology 61(9):919-924.
21. Paganini-Hill, A., and R. K. Ross. 1982. Reliability of Recall of Drug Usage and Other Health-Related Information. American Journal of Epidemiology 116(1):114-122.
22. Poisal, J. A. 2003-2004. Reporting of Drug Expenditures in the MCBS. Health Care Financing Review 25(2):23-36.
23. Selden, T., K. Levit, J. Cohen, S. H. Zuvekas, J. F. Moeller, D. McKusick, and R. H. Arnett. 2001. Reconciling Medical Expenditure Estimates from the MEPS and NHA, 1996. Health Care Financing Review 23(1):161-178.
24. Sing, M., J. S. Banthin, T. M. Selden, C. A. Cowan, and S. P. Keehan. 2006. Reconciling Medical Expenditure Estimates from the MEPS and NHEA, 2002. Health Care Financing Review 28(1):25-40.
25. Sjahid, S. I., P. D. van der Linden, and B. H. Stricker. 1998. Agreement between the Pharmacy Medication History and Patient Interview for Cardiovascular Drugs: The Rotterdam Elderly Study. British Journal of Clinical Pharmacology 45(6):591-595.
26. Van den Brandt, P. A., H. Petri, E. Dorant, R. A. Goldbohm, and S. Van de Crommert. 1991. Comparison of Questionnaire Information and Pharmacy Data on Drug Use. Pharmaceutisch Weekblad Scientific edition 13(2):91-96.
27. Williams, R. L. 2000. A Note on Robust Variance Estimation for Cluster-Correlated Data. Biometrics 56(2):645-646.
28. Wolters Kluwer Health, Inc. 2005. Master Drug Data Base (MDDBH)® Version 2.5 Documentation Manual. Indianapolis, Ind.: Wolters Kluwer Health, Inc.
29. Zodet, M. W., S. C. Hill, and G. E. Miller. 2010. Comparison of Retail Drug Prices in the MEPS and Market Scan: Implications for MEPS Editing Rules. Agency for Healthcare Research and Quality Working Paper No. 10001. http://gold.ahrq.gov.
30. Zuvekas, S. H., and G. L. Olin. 2009a. Validating Household Reports of Health Care Use in the Medical Expenditure Panel Survey. Health Services Research 44(5 Part I):1679-1700.
31. Zuvekas, S. H., and G. L. Olin 2009b. Accuracy of Medicare Expenditures in the Medical Expenditure Panel Survey. Inquiry 46(1):92-108.